ELVN Stock Price
Enliven Therapeutics, Inc.
ELVN stock price is $39.28 (-0.53% on the day), giving Enliven Therapeutics, Inc. a market cap of $2.89B. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
ELVN Stock Overview
- Price
- $39.28
- Previous close
- $39.49
- Open
- $38.99
- Market cap
- $2.89B
- P/E ratio
- -27.9
- 52-week range
- $14.79 - $62.32
- 1-year price target
- $72.54
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- NGS
- MarketXLS Rank
- 36
About Enliven Therapeutics, Inc.
Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer. The company's lead product candidates comprise ELVN-001, a small molecule kinase inhibitor which is in Phase 1 clinical trial to treat adults with chronic myeloid leukemia; and ELVN-002, a CNS penetrant and irreversible HER2 inhibitor that is in Phase 1 clinical trial for the treatment of non-small cell lung cancer (NSCLC) and other HER2 driven cancers and solid tumors. The company is headquartered in Boulder, Colorado.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ELVN | $39.28 | -0.5% | 1.22M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Enliven Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW